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ABSTRACT
Background: Human experimental pain models help to understand the
echanism of the underlying clinical pain conditions and can be adopted to test
nalgesic efficacy of drugs used in the management of pain. In early phases, the
linical development of new analgesic agents is severely hindered due to lack of
eliable sensitive tests for the experimental pain models.
Objective: The aim of the present study was to standardize and validate a
imple contact heat pain model that can be used for future screening of various
nalgesic agents.
Methods: The method was standardized by recording heat detection and heat
pain detection threshold in degrees centigrade in 24 healthy volunteers. Reproduc-
ibility of the test procedure was evaluated by recording the thermal threshold
parameters by a single observer on 2 sessions (inter-day reproducibility) and a second
observer on 1 session (inter-observer reproducibility) separately. Validity of model
was further tested by evaluating the analgesic effect of tramadol on 12 healthy
volunteers.
Results: Thermal pain model using contact heat method was found to produce
low variability with coefficient of variation 5%. Inter-observer and inter-day
reproducibility was very good, as shown by Bland–Altman Plot; with most of the
values within 2 SD. There was a significant difference in both heat detection threshold
and heat pain detection threshold produced by tramadol, as compared with placebo
(P  0.05).
Conclusions: The newly developed pain model produces a type of exper-
imental pain that is responsive to analgesic effects of tramadol at clinically
relevant doses. The model might be useful in early screening of new therapeutic
agents before proceeding to expensive clinical trials in acute and chronic pain
sufferers. (Curr Ther Res Clin Exp. 2011;72:233–242)
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INTRODUCTION
Pain is the most prevalent health care problem, and characterization of pain is of
major importance in the diagnosis and choice of treatment.1 Studies of analgesic
fficacy in patients already suffering pain raise ethical issues. Also, in clinical practice,
he different symptoms of the underlying disease or complaints relating to psycho-
ogical, cognitive, and social aspects of the illness, as well as systemic reactions such
s fever and general malaise, confound the characterization of pain.2 In contrast,
experimentally induced pain avoids some ethical issues and is often advantageous in
preclinical investigation of analgesics because of the close control of the environment
and the intensity and nature of the noxious stimulus.
Several experimental approaches have been used in the early screening of new analge-
sics. Commonly, these tests measure subjective pain after pain stimuli. However, these
approaches are limited mostly because of the poor standardization of subjective pain
ratings.3 Reproducibility is an important factor in the testing of analgesics, where it is
ecessary to repeat the pain stimulus several times during active and placebo treatments;
f reproducibility is good, the model can be useful in drug screening.4
An alternative for determining the effect of analgesics is quantitative sensory
esting (QST). QST has the particular advantage of being a functional test that
rovides a quantitative pain stimulus and assesses the subject’s individual response to
he stimulus.5,6 The repeatability of the visual analogue scale has been shown to be
poor in a setting of human experimental heat pain compared with thermal QST.7
QST also provides a reliable assessment of changes in pain thresholds.
Our objective was to standardize a simple thermal pain model using QST as a
functional test, applicable in early clinical trials with groups of reduced numbers of
subjects for the evaluation of a possible analgesic effect. Further validation of the
experimental model was carried out by assessing the analgesic effect of tramadol.
SUBJECTS AND METHODS
Subjects
Twenty-four healthy volunteers ranging in age from 21 to 35 years were studied.
he volunteers were given a short explanation of the purpose of the research and a
escription of the procedure to be followed. They were also given a description of any
easonably foreseeable risks and discomforts. Written consent to participate was
btained from each volunteer. Before it was initiated, the study was approved by the
nstitutional Ethics Committee on Research Involving Human Beings.
Contact Heat Method
Heat pain was induced using the Sensitometer HCP (Dhansai Laboratory, Mum-
ai, India) with a skin contact surface area of 4 cm2. The probe was kept in touch with
the volar aspect of the forearm of the nondominant arm, taking care to ensure that the
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S.K.R. Khambam et al.entire surface of the probe was in contact with the skin. The basal skin adaptation
temperature of the probe was maintained at 32°C. Tests were performed using the
method of limits (ie, ascending method of limits, where some property of stimulus
starts out at a level so low that the stimulus could not be detected, then this level is
gradually increased at a fixed rate until the participant reports that they are aware of
it), with change of 0.5°C/sec for heat detection and heat pain detection threshold
testing and the cut-off temperature was set to 49°C. The more rapid temperature
change used to determine pain thresholds was chosen to avoid sensitization of the skin
due to thermal stimuli. All tests were performed in the same room with an ambient
room temperature of 21°C (1°C) and always at the morning session. Volunteers
were blinded during the procedure and no auditory cues were given to indicate
stimulus onset. Volunteers were instructed to report the time point at which they
perceived heat sensation (warmth), that is, the heat detection threshold (HDT) and
the time point at which they perceived heat pain sensation, that is, the heat pain
detection threshold (HPDT). The sensory qualities were always tested in the same
order: HDT and HPDT. The recordings were noted in degrees centigrade. Four
measurements were performed for each threshold (HDT and HPDT) on the same
volar aspect of the nondominant forearm and the mean was taken. There was a gap
of at least 20 seconds between each measurement. In addition, to assess the repro-
ducibility of the method, each volunteer participated in 3 experimental sessions
separated by intervals of 4 to 5 days. The recordings of the thermal threshold
parameters were noted by a single observer on 2 sessions (inter-day reproducibility)
and the second observer on 1 session (inter-observer reproducibility) separately.
Effect of Tramadol
Twelve healthy male volunteers with a mean age of 31.3 (6.7) years participated
n the study. Volunteers were randomly assigned to receive either placebo or the
ramadol 50 mg at the morning session after a light breakfast, according to the
rossover design. There was a 1-week washout period between the drug and placebo
hases. Randomization of the sequence of placebo and active treatment periods was
erformed by a pharmacist who had no contact with the volunteers or the experi-
enter. On the day of experiment, the procedure, as described earlier, to detect
ensory qualities was carried out on the volar aspect of the nondominant forearm and
ll measurements were taken from the same site. HDT and HPDT were recorded at
aseline (0 minute) and then at 30 minutes, 60 minutes, 120 minutes, and 180
inutes after administration of the drug. During the application of the study drugs,
sedation score (0  awake, 1  tired, 2  asleep but arousable, 3  nonarousable)
as assessed every 10 minutes. All side effects were noted.
Statistical Analysis
The data on HDT and HPDT were recorded in degrees centigrade and presented
s mean, standard error, and coefficient of variance.
Bland–Altman plotting was performed for the assessment of method reproduc-bility.8 The relative (positive or negative) differences between each pair of measure-
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relationship appeared between the estimated values of mean and difference. The
Bland–Altman analysis was done to compare the values of HDT and HPDT obtained
by 2 observers separately. Similarly, the comparisons were also made to confirm the
reproducibility by analyzing the HDT and HPDT values obtained on 2 sessions.
The paired Student t test was used to compare the difference within the group and
etween the 2 groups, a value of P  0.05 was considered to indicate statistical
ignificance. All statistical analyses were performed using Graph Pad PRISM software
(Graph Pad Software Inc., San Diego, California).
RESULTS
Results of the method standardized refer to a group of 24 healthy volunteers, aged 21
to 35 years, who were apparently healthy on the basis of their medical examination
and laboratory investigations. In no subject was burn injury observed.
The Table lists the mean, standard error, and coefficient of variance of HDT and
PDT.
The relationship and Bland–Altman Plot comparing inter-day and inter-observer
easurements are shown in Figures 1A, 1B, 1C, and 1D.
In the Bland–Altman Plot of inter-day measurement of HDT and HPDT (Figures 1A
and 1B), there was no significant difference (P  0.05) in the values for reproducibility
reported between the sessions, and the range of most of the values was within 2 SD.
Similarly, there was good reproducibility between the differences among 2 ob-
servers shown as Bland–Altman Plot (Figures 1C and 1D) for HDT and the same was
observed with HPDT, showing less variation in reproducibility, with most of the
points lying within 2 SD (P  0.05).
Analgesic Efficacy
To confirm the validity of the method, we have used tramadol as a reference opioid
nalgesic. Twelve healthy male volunteers (mean age 31.3 [6.7] years; height 167.8 [6.2]
m; weight 65.6 [6.5] kg; and body mass index 23.1 [2.3] kg/m2) completed the study.
DT to Contact Heat Pain Method
HDT values increased markedly with the active treatment but remained un-
Table. Mean, SE, and coefficient of variation of heat detection threshold and heat pain
detection threshold (n  24).
Parameter Mean (°C) SE CV (%)
HDT 36.85 0.26 3.46
HPDT 44.97 0.24 2.62
CV  coefficient of variation; HDT  heat detection threshold; HPDT  heat pain detection threshold.hanged after placebo. Peak effects were observed 30 minutes after administration
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S.K.R. Khambam et al.(Figure 2). Tramadol 50 mg produced significant elevations of HDT at all time
points compared with placebo (P  0.01).
HPDT to Contact Heat Pain Method
HPDT values increased after administration of the active drug, but remained unchanged
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Figure 1. (A) Bland–Altman plot showing session 1 and session 2 differences in measure-
ments of heat detection threshold (HDT). (B) Bland–Altman plot showing ses-
sion 1 and session 2 differences in measurements of heat pain detection thresh-
old (HPDT). (C) Bland–Altman plot showing observer 1 and observer 2
differences in measurements of HDT. (D) BlandAltman plot showing observer
1 and observer 2 differences in measurements of HPDT.after placebo. Peak effects were observed 30minutes after administration (Figure 3). Tramadol
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Current Therapeutic Research50 mg produced significant elevations of HPDT at 30, 60, and 120 minutes compared with
placebo (P  0.05 at 60 and 120 minutes, P  0.01 at 30 minutes).
Mild sedation was seen in some volunteers, but never exceeded sedation score 1.
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Figure 2. Thermal sensory threshold. The effect of placebo and tramadol on the tested
heat detection threshold (HDT). Data are expressed as mean (SE) of the differ-
ence between the baseline threshold values measured before (0) and 30 min-
utes, 60 minutes, 120 minutes, and 180 minutes after administration. Statisti-
cal significance of change in threshold compared with placebo (*P < 0.01).
Placebo Tramadol
*P < 0.01, †P < 0.05 
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Figure 3. Thermal pain threshold. The effect of placebo and tramadol on the tested heat pain
detection threshold (HPDT). Data are expressed as mean (SE) of the difference
between the baseline threshold values measured before (0) and 30 minutes, 60
minutes, 120 minutes, and 180 minutes after administration. Statistical signifi-
cance of change in threshold compared with placebo (*P < 0.01, †P < 0.05).
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The present study describes an experimental pain technique in humans that is
sensitive to detect changes in HDT and HPDT using tramadol at doses known to be
effective in acute pain. In addition, it is simple to perform and requires few personnel
to conduct the study. Although a flare response was observed in the vast majority of
subjects, no burn injuries occurred in any of our subjects.
In the present study, data obtained on HDT and HPDT was highly reproducible
with a coefficient of variance 5%. One well-known index of accuracy of a method
is the coefficient of variation (SD/mean) and coefficient of variance 10% is consid-
ered to be the hallmark of a good assay for a subjective phenomenon.9
In addition, the data obtained for both HDT and HPDT on the relationship and
land–Altman plot comparing inter-day and inter-observer measurements were to
valuate the reproducibility of an experimental pain model. There was no significant
ifference in the values for reproducibility reported between the observers and
etween the sessions and most of the values range within mean (2 SD) of the
land–Altman plot. Reproducibility is an important factor in the testing of analge-
ics, where it is necessary to repeat the pain stimulation several times during active
nd placebo treatments. Earlier studies aimed to present data of heat-induced pain
nd assessed and reported inter-session repeatability employing methods based on
tandard recognized statistical technique.8
The major criticism of experimental pain techniques is short duration of exposure
o the stimuli, which differs from clinical pain. The ability of this method to
iscriminate tramadol from placebo was attributed to the tonic nature of the stim-
lus. However, it is probably irrelevant whether the experimental pain stimulus is
elivered as phasic or tonic. It is more important that the stimulus reaches sufficient
ntensity to produce pain sensation (burning quality due to activity in the unmyeli-
ated C nociceptors) because it is the latter sensation that is reliably attenuated by
oth non-narcotic and narcotic analgesics.10
The tonic heat model also offers an important theoretical advantage compared to
epetitive-phasic stimulation models. In the latter, the subject goes through an
lternation of pain anticipation and pain-relief states. There is ample evidence from
uman brain mapping studies that both anticipation and termination of a painful
vent can activate the brain reward system,11,12 and that this process is modulated by
opaminergic mechanisms.13 This inter-relationship makes it difficult to disentangle
pain-related and reward-related changes in dopamine receptor availability.
In the present study, we have utilized the crossover design to compare the analgesic
effect of tramadol and placebo in healthy subjects and a single investigator performed
all pain assessments. In general, parallel studies give a weaker statistical power than
a crossover design, demanding larger sample sizes.14 In case of crossover-designed
tudies, it is important that the investigator is the same in all pain assessments
ecause gender and appearance of the investigator can influence the pain rating of the
olunteers.15
The sensitivity of a given experimental model for detecting analgesia is affected by
he method used to measure this pain. Good sensitivity of a model is obtained by
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(noise). In the study by Thurauf et al, the value of objective pain assessment was
shown because an effect of tramadol was found on evoked brain potentials only and
not on pain ratings.16 It is, however, important to note that, although evoked
potentials can be a sensitive measure of nociceptive processes, they only measure a
single dimension of pain. Pain is a multidimensional sensation, and this is reflected
better in the subjective pain measure. This limits the translation of analgesic effect on
evoked brain potentials into effect on clinical pain measures. In the present study, we
have used QST as a functional test that provides a reliable assessment of changes in
pain thresholds. Also, thermal QST (heat and cold) allows a distinction between
predominantly C-fiber activity and A-delta fiber activity.
The study duration of the drug was based on consideration of Tmax. Thus,
tramadol, which has a Tmax of 3 hours was tested for 3 hours. There is strong
evidence that for most analgesics, clinical analgesia is not a direct function of drug
concentration. Therefore, the time course of analgesic effect for analgesic drugs is
characteristic of pharmacologic effect (analgesia), consistent with a role of an endog-
enous substance in the analgesic effect. In the present study, the time to peak effect
after tramadol occurred at 30 minutes.
The kinetic profile is necessary to determine when it is optimal to perform the pain
tests, bearing in mind that bad timing of pain testing can jeopardize an otherwise
well-designed trial. For opioids, it is particularly important to remember that they
often need to cross the blood–brain barrier and enter the central nervous system to
have an analgesic effect. This causes a lag time to the onset of analgesia. The study
design should consider these different lag times for different opioids. In the present
study, considering the Tmax of the tramadol, we performed all pain assessments at 30,
60, 120, and 180 minutes post-drug.
In the present study, subjects were given a light breakfast because oral adminis-
tration of tramadol with food does not substantially affect its rate or extent of
absorption. Also, fasting the subjects to increase the absorption of analgesics, we
believe, can introduce additional stress. However, dietary manipulation can alter
human pain sensitivity in that rapid increases in circulating glucose produce a
decrease in the ability to tolerate pain.
In our study, as compared with placebo administration, tramadol produced a
substantial analgesic effect. Many experimental studies in healthy volunteers have
failed to determine the pharmacodynamic profile of agents with moderate analgesic
activity in clinically relevant doses.17,18 There have been many attempts to develop
experimental pain models in humans. Few techniques have been proven useful for
evaluation of analgesics19 or for the elucidation of pain mechanisms.20
Response to pain stimulus is highly subjective and varies from subject to subject,
ecessitating proper sample size estimation for evaluation of an analgesic drug on
uman participants. For method optimization and standardization, we have included
total of 24 healthy human volunteers in our experiment. Trials involving experi-
ental pain often use small sample sizes because the variation of the outcome
easures is less than in traditional clinical trials. Trials with fewer than 10 to 12
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it has been shown that experimental models with a high reproducibility and a sample
size 10 are powered to show the effect of analgesics.21
In the method described here, tramadol induced a considerable increase in the
DT and HPDT, indicating that the study design was valid and capable of detecting
n analgesic effect on heat pain. There are still major problems in the exact deter-
ination of the activated pathways and pain mechanisms in human experimental
ain.22 Nevertheless, the experimental human models allow the possibility to obtain
reproducible results in test-retest experiments and be useful for drug screening.23
CONCLUSIONS
There is a great practical need for a dependable method of assessing the effects of
analgesic drugs on experimental pain in humans. Results of the present study show
that appropriate use of the contact heat method technique produces a type of
experimental pain that is responsive to the analgesic effects of tramadol. Our data also
indicate that the variation between different subject’s thresholds is less than what has
been expected heretofore. The model might potentially allow analgesic effects of new
compounds to be quantified in healthy volunteers before proceeding to expensive
clinical trials in acute and chronic pain sufferers.
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